Accueil4DX • ASX
add
4DMedical Ltd
Dernière clôture
0,50 $
Variation sur la journée
0,53 $ - 0,56 $
Plage sur l'année
0,41 $ - 0,83 $
Capitalisation boursière
217,02 M AUD
Volume moyen
953,90 k
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
ASX
Actualités
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
(AUD) | juin 2024info | Variation Y/Y |
---|---|---|
Chiffre d'affaires | 1,48 M | 1 172,70 % |
Charges d'exploitation | 12,56 M | 11,42 % |
Résultat net | -10,19 M | -33,78 % |
Marge bénéficiaire nette | -687,84 | 89,49 % |
Bénéfice par action | — | — |
EBITDA | -11,09 M | -5,51 % |
Taux d'imposition effectif | -0,01 % | — |
Bilan
Total des actifs
Total du passif
(AUD) | juin 2024info | Variation Y/Y |
---|---|---|
Trésorerie/Invest. court terme | 30,61 M | -56,01 % |
Total des actifs | 120,02 M | 29,16 % |
Total du passif | 49,09 M | 128,71 % |
Total des capitaux propres | 70,93 M | — |
Actions en circulation | 410,53 M | — |
Ratio cours/valeur comptable | 2,91 | — |
Rentabilité des actifs | -23,28 % | — |
Retour sur capitaux | -36,73 % | — |
Flux de trésorerie
Variation nette en trésorerie
(AUD) | juin 2024info | Variation Y/Y |
---|---|---|
Résultat net | -10,19 M | -33,78 % |
Trésorerie (opérations) | -8,06 M | 8,54 % |
Trésorerie (invest.) | -339,48 k | -21,29 % |
Trésorerie (financement) | -233,98 k | -101,11 % |
Variation nette en trésorerie | -8,64 M | -172,48 % |
Flux de trésorerie dispo. | -5,43 M | 13,25 % |
À propos
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Date de fondation
2013
Site Web
Employés
145